高危前列腺癌：泌尿肿瘤学领域中极具挑战性的疾病。
High-Risk Prostate Cancer: A Very Challenging Disease in the Field of Uro-Oncology.
作者信息
Napodano Giorgio, Ferro Matteo, Sanseverino Roberto
机构信息
Department of Urology, Umberto I Hospital, ASL Salerno, 84014 Nocera Inferiore, Italy.
Department of Urology, European Institute of Oncology, IRCCS, 20141 Milan, Italy.
出版信息
Diagnostics (Basel). 2021 Feb 26;11(3):400. doi: 10.3390/diagnostics11030400.
Abstract
Prostate cancer (PCa) is the most common cancer in males and affects 16% of men during their lifetime [...].
摘要
前列腺癌（PCa）是男性中最常见的癌症，在男性一生中发病率为16%[……]
相似文献
1
High-Risk Prostate Cancer: A Very Challenging Disease in the Field of Uro-Oncology.高危前列腺癌：泌尿肿瘤学领域中极具挑战性的疾病。
Diagnostics (Basel). 2021 Feb 26;11(3):400. doi: 10.3390/diagnostics11030400.
2
A National Survey of Radiation Oncologists and Urologists on Perceived Attitudes and Recommendations of Active Surveillance for Low-Risk Prostate Cancer.一项针对放射肿瘤学家和泌尿科医生的全国性调查，了解他们对低危前列腺癌主动监测的看法和推荐意见。
Clin Genitourin Cancer. 2019 Jun;17(3):e472-e481. doi: 10.1016/j.clgc.2019.01.008. Epub 2019 Feb 7.
3
Consensus statement on definition, diagnosis, and management of high-risk prostate cancer patients on behalf of the Spanish Groups of Uro-Oncology Societies URONCOR, GUO, and SOGUG.代表西班牙泌尿肿瘤学会 URONCOR、GUO 和 SOGUG 的专家组关于高危前列腺癌患者的定义、诊断和管理的共识声明。
Clin Transl Oncol. 2018 Mar;20(3):392-401. doi: 10.1007/s12094-017-1726-y. Epub 2017 Aug 7.
4
Measuring testosterone and testosterone replacement therapy in men receiving androgen deprivation therapy for prostate cancer: A survey of UK uro-oncologists' opinions and practice.测定接受雄激素剥夺疗法治疗前列腺癌的男性的睾酮和睾酮替代疗法：对英国泌尿肿瘤学家意见和实践的调查。
Int J Clin Pract. 2019 Sep;73(9):1-6. doi: 10.1111/ijcp.13292. Epub 2018 Dec 4.
5
Current status of uro-oncology training during urology residency and the need for fellowship programs: An international questionnaire study.泌尿外科住院医师培训期间尿路上皮肿瘤学培训的现状及对专科 fellowship 项目的需求：一项国际问卷调查研究
Turk J Urol. 2020 Nov;46(6):455-459. doi: 10.5152/tud.2020.20276. Epub 2020 Oct 21.
6
Anxiety and depression symptoms in adult males in Atlantic Canada with or without a lifetime history of prostate cancer.加拿大大西洋沿岸地区有或没有前列腺癌病史的成年男性的焦虑和抑郁症状。
Psychooncology. 2020 Feb;29(2):280-286. doi: 10.1002/pon.5244. Epub 2019 Dec 26.
7
Primary cancers before and after prostate cancer diagnosis.前列腺癌诊断前后的原发性癌症。
Cancer. 2012 Dec 15;118(24):6207-16. doi: 10.1002/cncr.27672. Epub 2012 Jun 6.
8
9
Degarelix therapy for prostate cancer in a real-world setting: experience from the German IQUO (Association for Uro-Oncological Quality Assurance) Firmagon® registry.德加雷lix在真实世界中治疗前列腺癌：来自德国IQUO（泌尿肿瘤质量保证协会）Firmagon®注册研究的经验
BMC Urol. 2015 Dec 16;15:122. doi: 10.1186/s12894-015-0116-4.
10
Knowledge, attitudes, and practices towards prostate cancer screening amongst men living in the southern Italian peninsula: the Prevention and Research in Oncology (PRO) non-profit Foundation experience.居住在意大利半岛南部的男性对前列腺癌筛查的知识、态度和实践：预防和肿瘤学研究（PRO）非营利基金会的经验。
World J Urol. 2017 Dec;35(12):1857-1862. doi: 10.1007/s00345-017-2074-9. Epub 2017 Aug 5.
引用本文的文献
1
Efficacy and safety of neoadjuvant chemohormonal therapy for high-risk prostate cancer treated with robot-assisted laparoscopic radical prostatectomy: a propensity score-matched analysis (the MSUG94 group).新辅助化疗激素疗法联合机器人辅助腹腔镜根治性前列腺切除术治疗高危前列腺癌的疗效与安全性：倾向评分匹配分析（MSUG94组）
Int Urol Nephrol. 2025 Mar;57(3):809-816. doi: 10.1007/s11255-024-04268-2. Epub 2024 Nov 8.
本文引用的文献
1
NCCN Guidelines Updates: Management of Prostate Cancer.NCCN 指南更新：前列腺癌的管理。
J Natl Compr Canc Netw. 2019 May 1;17(5.5):583-586. doi: 10.6004/jnccn.2019.5011.
2
Heterogeneity in Definitions of High-risk Prostate Cancer and Varying Impact on Mortality Rates after Radical Prostatectomy.高危前列腺癌定义的异质性及其对根治性前列腺切除术后死亡率的不同影响。
Eur Urol Oncol. 2018 Jun;1(2):143-148. doi: 10.1016/j.euo.2018.02.004. Epub 2018 May 15.
3
Assessing the Role and Optimal Duration of Hormonal Treatment in Association with Salvage Radiation Therapy After Radical Prostatectomy: Results from a Multi-Institutional Study.评估根治性前列腺切除术后挽救性放疗联合激素治疗的作用和最佳持续时间：多机构研究的结果。
Eur Urol. 2019 Oct;76(4):443-449. doi: 10.1016/j.eururo.2019.02.004. Epub 2019 Feb 22.
4
SPCG-15: a prospective randomized study comparing primary radical prostatectomy and primary radiotherapy plus androgen deprivation therapy for locally advanced prostate cancer.SPCG - 15：一项比较局部晚期前列腺癌的根治性前列腺切除术与根治性放疗加雄激素剥夺治疗的前瞻性随机研究。
Scand J Urol. 2018 Oct-Dec;52(5-6):313-320. doi: 10.1080/21681805.2018.1520295. Epub 2018 Dec 26.
5
Surgery vs Radiotherapy in the Management of Biopsy Gleason Score 9-10 Prostate Cancer and the Risk of Mortality.手术与放疗在处理活检前列腺癌评分 9-10 级及死亡率风险中的比较。
JAMA Oncol. 2019 Feb 1;5(2):213-220. doi: 10.1001/jamaoncol.2018.4836.
6
Comparative Effectiveness of Radical Prostatectomy Versus External Beam Radiation Therapy Plus Brachytherapy in Patients with High-risk Localized Prostate Cancer.高危局限性前列腺癌患者行根治性前列腺切除术与外照射放疗联合近距离治疗的疗效比较。
Eur Urol. 2019 Apr;75(4):552-555. doi: 10.1016/j.eururo.2018.10.032. Epub 2018 Nov 10.
7
Duration of Androgen Deprivation Therapy in High-risk Prostate Cancer: A Randomized Phase III Trial.高危前列腺癌雄激素剥夺治疗的持续时间：一项随机 III 期试验。
Eur Urol. 2018 Oct;74(4):432-441. doi: 10.1016/j.eururo.2018.06.018. Epub 2018 Jul 3.
8
Radical Prostatectomy, External Beam Radiotherapy, or External Beam Radiotherapy With Brachytherapy Boost and Disease Progression and Mortality in Patients With Gleason Score 9-10 Prostate Cancer.根治性前列腺切除术、外照射放疗、外照射放疗联合近距离放疗增敏与 Gleason 评分 9 - 10 前列腺癌患者的疾病进展及死亡率
JAMA. 2018 Mar 6;319(9):896-905. doi: 10.1001/jama.2018.0587.
9
Effect of Prostate Cancer Severity on Functional Outcomes After Localized Treatment: Comparative Effectiveness Analysis of Surgery and Radiation Study Results.前列腺癌严重程度对局部治疗后功能结局的影响：手术和放疗研究结果的比较效果分析。
Eur Urol. 2018 Jul;74(1):26-33. doi: 10.1016/j.eururo.2018.02.012. Epub 2018 Feb 28.
10
Brachytherapy-Based Radiotherapy and Radical Prostatectomy Are Associated With Similar Survival in High-Risk Localized Prostate Cancer.基于近距离放射治疗和根治性前列腺切除术的治疗与高危局限性前列腺癌的相似生存相关。
J Clin Oncol. 2018 Apr 20;36(12):1192-1198. doi: 10.1200/JCO.2017.75.9134. Epub 2018 Feb 28.
Zotero 插件